Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy

Cancer Gene Therapy, Published online: 09 December 2022; doi:10.1038/s41417-022-00569-9Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy

Source: Cancer Gene Therapy - December 9, 2022 Category: Cancer & Oncology Authors: Xisong Liang Zeyu Wang Ziyu Dai Hao Zhang Jian Zhang Peng Luo Zaoqu Liu Zhixiong Liu Kui Yang Quan Cheng Mingyu Zhang Source Type: research